Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-008837

President and CEO sold 3,595 shares at $12.66 ($45,513)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2022-02-09 Sale −3,595 $12.66 $45,513 1,239,387 D: show line 1 in the form
Open-market sales · 3,595 sh · avg $12.66 · $45,513
Loading xslF345X03/doc4.xml…